Calumet (CLMT) EBIAT (2023 - 2025)
Calumet (CLMT) has disclosed EBIAT for 3 consecutive years, with -$37.3 million as the latest value for Q4 2025.
- Quarterly EBIAT rose 8.35% to -$37.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$33.8 million through Dec 2025, up 84.77% year-over-year, with the annual reading at -$33.8 million for FY2025, 84.77% up from the prior year.
- EBIAT for Q4 2025 was -$37.3 million at Calumet, down from $313.4 million in the prior quarter.
- The five-year high for EBIAT was $313.4 million in Q3 2025, with the low at -$162.0 million in Q1 2025.
- Average EBIAT over 3 years is -$22.3 million, with a median of -$41.5 million recorded in 2023.
- Peak annual rise in EBIAT hit 411.53% in 2025, while the deepest fall reached 289.42% in 2025.
- Over 3 years, EBIAT stood at -$48.0 million in 2023, then rose by 15.21% to -$40.7 million in 2024, then increased by 8.35% to -$37.3 million in 2025.
- According to Business Quant data, EBIAT over the past three periods came in at -$37.3 million, $313.4 million, and -$147.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.